原发性骨质疏松症的中医认识及治疗
Understanding and Treatment of Primary Osteoporosis in Traditional Chinese Medicine
DOI: 10.12677/acm.2025.1561692, PDF,   
作者: 李宗颖:云南中医药大学第一临床医学院,云南 昆明
关键词: 骨质疏松症中医药防治认识Osteoporosis Traditional Chinese Medicine Prevention and Treatment Understanding
摘要: 骨质疏松症(osteoporosis, OP)是一种以骨量减少、骨骼微结构退化为特征的全身性骨病,发病率高且对健康构成重大威胁,尤其在老龄化日益加剧的背景下,其发病率不断上升。中医学认为,骨质疏松的核心病机在于肾精亏虚,可归属于“骨痿”“骨枯”等病证范畴。基于“肾主骨生髓”理论,中医治疗以补肾益精为主,辅以辨证施治,注重整体调理。在治疗方面,中医药表现出显著优势。单味中药如淫羊藿、巴戟天等通过多通路、多靶点调节骨代谢;中药复方如左归丸、金匮肾气丸等,通过药物协同作用改善骨密度和微结构;针灸、艾灸及穴位埋线等中医特色外治法,结合太极拳、易筋经等传统功法锻炼,促进骨骼健康并有效缓解病情。中医药治疗以副作用少、安全性高及长期使用的特点受到认可。中医药在骨质疏松症的防治中展现了广阔前景,与现代医学相辅相成,为患者提供了综合治疗策略,有助于推动中医药在慢性病领域的持续发展。
Abstract: Osteoporosis is a systemic bone disease characterized by reduced bone mass and degeneration of bone microstructure. It has a high incidence rate and poses a significant threat to health. Especially against the backdrop of an increasingly aging population, its incidence rate keeps rising. According to traditional Chinese medicine, the core pathogenesis of osteoporosis lies in the deficiency of kidney essence, which can be classified into the categories of diseases such as “bone atrophy” and “bone dryness”. Based on the theory that “the kidney governs the bones and generates marrow”, traditional Chinese medicine treatment mainly focuses on tonifying the kidney and enriching essence, supplemented by syndrome differentiation and treatment, and emphasizes overall conditioning. In terms of treatment, traditional Chinese medicine shows significant advantages. Single traditional Chinese medicines such as Epimedium and Morinda officinalis regulate bone metabolism through multiple pathways and targets. Traditional Chinese medicine compound prescriptions such as Zuogui Pills and Jinkui Shenqi Pills improve bone density and microstructure through the synergistic effect of drugs. Traditional Chinese medicine external treatment methods such as acupuncture, moxibustion and acupoint embedding, combined with traditional exercises like Tai Chi and Yijin Jing, promote bone health and effectively alleviate the condition. Traditional Chinese medicine treatment is recognized for its characteristics of few side effects, high safety and long-term use. Traditional Chinese medicine has shown broad prospects in the prevention and treatment of osteoporosis, complementing modern medicine and providing patients with comprehensive treatment strategies, which is conducive to promoting the continuous development of traditional Chinese medicine in the field of chronic diseases.
文章引用:李宗颖. 原发性骨质疏松症的中医认识及治疗[J]. 临床医学进展, 2025, 15(6): 8-13. https://doi.org/10.12677/acm.2025.1561692

参考文献

[1] Dawson-Hughes, B., Looker, A.C., Tosteson, A.N.A., Johansson, H., Kanis, J.A. and Melton, L.J. (2011) The Potential Impact of the National Osteoporosis Foundation Guidance on Treatment Eligibility in the USA: An Update in NHANES 2005-2008. Osteoporosis International, 23, 811-820. [Google Scholar] [CrossRef] [PubMed]
[2] Kasturi, G.C. and Adler, R.A. (2011) Osteoporosis: Nonpharmacologic Management. PM&R, 3, 562-572. [Google Scholar] [CrossRef] [PubMed]
[3] Feng, Y.Y., Xiu, L.L. and Su, L. (2014) Drug Therapy for Osteoporosis. Medical Recapitulate, 20, 105-109.
[4] Rossi, L.M.M., Copes, R.M., Dal Osto, L.C., Flores, C., Comim, F.V. and Premaor, M.O. (2018) Factors Related with Osteoporosis Treatment in Postmenopausal Women. Medicine, 97, e11524. [Google Scholar] [CrossRef] [PubMed]
[5] Klop, C., Welsing, P.M.J., Elders, P.J.M., Overbeek, J.A., Souverein, P.C., Burden, A.M., et al. (2015) Long-Term Persistence with Anti-Osteoporosis Drugs after Fracture. Osteoporosis International, 26, 1831-1840. [Google Scholar] [CrossRef] [PubMed]
[6] Sun, P., Zhang, C., Huang, Y., Yang, J., Zhou, F., Zeng, J., et al. (2022) Jiangu Granule Ameliorated OVX Rats Bone Loss by Modulating Gut Microbiota-SCFAs-Treg/Th17 Axis. Biomedicine & Pharmacotherapy, 150, Article ID: 112975. [Google Scholar] [CrossRef] [PubMed]
[7] 李磊, 郑怀亮, 寇玉, 等. 淫羊藿苷诱导骨髓间充质干细胞成骨细胞分化的研究[J]. 中华中医药杂志, 2018, 33(6): 2599-2601.
[8] 张锦明, 田滢舟, 赵玲, 熊莉华, 王丘平, 宋薇, 温建炫. 淫羊藿苷促进骨髓间充质干细胞成骨分化缓解小鼠骨质疏松的机制[J]. 中国组织工程研究, 2022, 26(19): 2991-2996.
[9] 刘文静, 杨娟, 张楚天, 孙攀, 黄美雅, 黄云梅. 巴戟天抗去卵巢骨质疏松大鼠的血清代谢组分析[J]. 中国药理学通报, 2022, 38(3): 446-453.
[10] 王健, 张驰. 基于Wnt/β-连环素通路探讨补骨脂素对骨质疏松症大鼠的影响[J]. 世界中医药, 2022, 17(12): 1697-1702.
[11] 赵晶. 杜仲叶提取物山奈酚对卵巢去势大鼠骨生成的影响及其与mTOR信号通路的关系研究[D]: [博士学位论文]. 南昌: 南昌大学, 2019
[12] 冯天笑, 黄湘龙, 霍路遥, 王平. 基于网络药理学探讨黄芪-熟地黄药对治疗骨质疏松症的作用机制[J]. 中国医院用药评价与分析, 2021, 21(10): 1157-1164.
[13] 刘飞祥, 林子璇, 徐道明, 等. 左归丸调节β-2AR介导的RANKL/OPG信号通路改善去卵巢大鼠骨量和显微结构水平[J]. 中国实验方剂学杂志, 2019, 25(18): 1-8.
[14] 王剑, 郑洪新, 张锦萍, 等. 补肾壮骨中药复方对去卵巢骨质疏松症大鼠骨组织 Dlx5 mRNA 及蛋白表达的影响[J]. 中国中医基础医学杂志, 2015, 21(10): 1238-1240.
[15] 张倩, 杨旭, 王媛, 等. 金匮肾气丸对去势大鼠骨微结构及 ALP、OPG、IL-6的影响[J]. 中国骨质疏松杂志, 2020, 26(10): 1475-1480.
[16] 原淳淳, 艾尔扎提∙艾尔宝, 王达宝, 等. 去卵巢大鼠全身肌肉、脂肪和雌二醇含量与骨密度的相关性及补肾健脾穴位针刺的调节作用[J]. 中华中医药杂志, 2020, 35(1): 434-436.
[17] 黎彦红, 王亚军. 灸法治疗骨质疏松症的临床应用与实验研究进展[J]. 按摩与康复医学, 2022, 13(8): 78-80.
[18] 董珍珍, 王谦, 李风雷, 等. 艾灸在“治未病”中的研究进展[J]. 巴楚医学, 2022, 5(2): 125-128.
[19] 彭农建, 钟鹏程, 赵新红. 穴位埋线治疗原发性骨质疏松症的临床研究[J]. 中医药导报, 2018, 24(12): 72-74.
[20] Chan, K., Qin, L., Lau, M., Woo, J., Au, S., Choy, W., et al. (2004) A Randomized, Prospective Study of the Effects of Tai Chi Chun Exercise on Bone Mineral Density in Postmenopausal Women. Archives of Physical Medicine and Rehabilitation, 85, 717-722. [Google Scholar] [CrossRef] [PubMed]
[21] 于莹. 4种中国传统健身运动疗法对中老年人骨质疏松症的网状Meta分析[J]. 中国体育科技, 2020, 56(9): 37-44.
[22] 陈文亮, 毛一凡, 张佳锋, 等. 益气温经方联合新编五禽戏对绝经后骨量减低患者的临床疗效观察[J]. 中国骨质疏松杂志, 2018, 24(7): 954-958.
[23] 李静雅, 程亮. 48 w不同频率太极拳练习对老年女性骨密度的影响[J]. 中国骨质疏松杂志, 2017, 23(10): 1309-1312.